UCL scientists receive £997,000 from the Type 1 Diabetes Grand Challenge

The FDA gave Lari­mar Ther­a­peu­tics the go-ahead to in­tro­duce a high­er dose of its Friedre­ich’s atax­ia treat­ment in a Phase II study. The biotech an­nounced

Nu­va­tion Bio plans to buy An­Heart Ther­a­peu­tics in an all-stock deal, the can­cer drug de­vel­op­ers said Mon­day morn­ing, in a move that could turn Nu­va­tion